Rojo MJ

Language: Spanish
References: 17
Page: 78-83
PDF size: 234.37 Kb.

ABSTRACT

Currently worldwide, the transfusion of blood components cannot be done without residual risks, as compared to those countries with a high human development index, mostly in Europe, that have blood donation systems based on 100% repeat volunteer donors and use molecular biology techniques in screening for infectious diseases. In Latin America and the Caribbean countries, prevention of transfusion-transmissible diseases requires special and different strategies due to several factors: the high prevalence of replacement donors, their specific geographical location, climate, genetic, and sociocultural status of the population make them vulnerable to endemic diseases such as dengue, malaria, and Chagas disease. Thus it is necessary to create local approaches to increase blood safety and achieve the goals set by the Pan American Health Organization.

REFERENCES

1. Dwyre DM, Holand PV. Hepatitis viruses. En: Barbara JAJ, Regan FAM, Contreras MC, eds. Transfusion Microbiology. Cambridge: Cambridge University Press; 2008. p. 9-23.

2. Dwyre DM, Fernando LP, Holland PV. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang. 2011; 100(1):92-8.

3. World Health Organization. Blood Safety. Fact sheet n.o 279. 2011. [Internet] Consultado el 30 de julio de 2012. Disponible en: http://www. who.int/worldblooddonorday/media/who_blood_safety_factsheet_ 2011.pdf

4. Secretaría de Salud. Centro Nacional de Transfusión Sanguínea. Informes mensuales de ingresos y egresos de sangre y sus componentes y enfermedades transmisibles por transfusión. México, 2012.

5. Pan American Health Organization, World Health Organization. Supply of Blood for Transfusion in the Caribbean and Latin American Countries in 2006, 2007, 2008, and 2009: Progress since 2005 of the Regional Plan of Action for Transfusion Safety. 2011.

6. World Health Organization. Making the most of World Blood Donor Day. [Internet] Consultado el 30 de julio de 2012. Disponible en: http://www. who.int/worldblooddonorday/resources/making_the_most_of_wbdd.pdf

7. Zou S, Stramer SL, Notari EP, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion. 2009;49:1609-20.

8. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion. 2010;50:1495-504.

9. Pan American Health Organization. 46th Directing Council. Progress Report on the Regional Initiative for Blood Safety and Plan of Action for 2006-2010. Document CD46/16, 26-30 September 2005.

10. Rojo J. Blood supply system in Mexico. ISBT Science Series. 2012;7:244-50.

11. Rojo J, Arroyo A, Estrada J. Práctica Transfusional en México. Consumos, Proyecciones y Acciones de Mejora. En: Martínez J, D´Artote AL, México, D.F. Ediciones AMMTAC; 2012. p. 47-55.

12. Arroyo A, Estrada J, Rojo J. Prevalencia del virus de la hepatitis B en donadores de sangre mexicanos. Rev Med Hosp Gen Mex. 2010;73(2): 83-7.

13. Arroyo A, Torres H, Estrada C, Rojo J. Estimated risk for transfusion transmitted infectious diseases in Mexico. Vox Sanguinis. 2011;101(Suppl. 1):194.

14. Secretaría de Salud. Centro Nacional de Transfusión Sanguínea. Informe de resultados del control de calidad externo en serología de la Red Nacional de Laboratorios de Banco de Sangre. México, 2012.

15. Pan American Health Organization. Eligibility for Blood Donation: Recommendations for Education and Selection of Prospective Blood Donors- Washington, D.C. 2009.

16. Pan American Health Organization. Recommendations for Estimating the Need for Blood and Blood Components, Washington, D.C. 2010.

17. Organización Panamericana de la Salud. Estándares de Trabajo para Servicios de Sangre. 3.a ed. Washington; 2011.